Entelexo (YC W21)

Creating a new class of drugs to address incurable autoimmune diseases

Pitch Video

Investor Panel

Irvine CA

Technology Bio Tech Healthcare Moonshots Science

>$1M raised to date, plus $310k on the same terms

CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease

Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year

Our intellectual property is patent-protected (patent owned by the Company)

Raising $2M for pre-clinical product development and IND enabling animal studies